Acro Biomedical (ACBM) EPS (Weighted Average and Diluted) (2021 - 2025)
Acro Biomedical's quarterly EPS (Weighted Average and Diluted) came in at $0.0 in Q4 2025, up 498.44% year-on-year from $0.0 in Q4 2024, and up 136.1% quarter-over-quarter from -$0.0 in Q3 2025.
Acro Biomedical has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at $0.0 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 498.44% year-over-year to $0.0; the trailing twelve-month figure through Dec 2025 stood at -$0.0 (down 139.13% YoY), and the FY2025 full-year result was -$0.0, down 139.13% from the prior year.
- EPS (Weighted Average and Diluted) for Q4 2025 stood at $0.0, up from -$0.0 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.0 in Q4 2025, with the low at -$0.07 in Q4 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.02, with a median of -$0.0 recorded in 2023.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 498.44% in 2025, while the deepest fall reached 1051.72% in 2025.
- Tracing ACBM's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.07 in 2021, then increased by 16.08% to -$0.06 in 2022, then jumped by 99.49% to -$0.0 in 2023, then surged by 41.49% to -$0.0 in 2024, then surged by 498.44% to $0.0 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.0 (Q4 2025), -$0.0 (Q3 2025), and -$0.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 0.07 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 0.06 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 0.07 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 0.04 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 0.07 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 0.06 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 0.07 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 0.05 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 0.06 |
| 10 | Acro Biomedical | - | - | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.07 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -0.07 |
| Dec 31, 2021 | -0.07 |